购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

3-TYP

产品编号 T4108Cas号 120241-79-4
别名 3-(1H-1,2,3-triazol-4-yl) pyridine

3-TYP (3-(1H-1,2,3-triazol-4-yl) pyridine) 是选择性SIRT3抑制剂,IC50值为 16 nM。它对 SIRT1 和 SIRT2 的选择性强,IC50值分别为 88 和 92 nM。

3-TYP
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

3-TYP

纯度: 100.00%
产品编号 T4108 别名 3-(1H-1,2,3-triazol-4-yl) pyridineCas号 120241-79-4

3-TYP (3-(1H-1,2,3-triazol-4-yl) pyridine) 是选择性SIRT3抑制剂,IC50值为 16 nM。它对 SIRT1 和 SIRT2 的选择性强,IC50值分别为 88 和 92 nM。

规格价格库存数量
1 mg¥ 218现货
5 mg¥ 481现货
10 mg¥ 823现货
25 mg¥ 1,490现货
50 mg¥ 2,490现货
100 mg¥ 3,770现货
500 mg¥ 8,380现货
1 mL x 10 mM (in DMSO)¥ 481现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"3-TYP"的相关化合物库

选择批次:
纯度:100.00%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
3-TYP (3-(1H-1,2,3-triazol-4-yl) pyridine) is a selective SIRT3 inhibitor.
靶点活性
SIRT2:92 nM, SIRT1:88 nM, SIRT3:16 nM
体外活性
3-TYP显著减弱了在Cd暴露的HepG2细胞中,褪黑激素诱导的去乙酰化SOD2表达和SOD2活性的增加。3-TYP抑制了褪黑激素增强的SIRT3活性,但并不影响SIRT3蛋白表达。3-TYP预处理逆转了褪黑激素对镉(Cd)引起的线粒体来源的O2•−产生和自噬细胞死亡的保护效果。
体内活性
3-TYP显著降低SIRT3活性,增加了SOD2的乙酰化水平,但不影响SIRT3的表达。3-TYP通过减少LVEF和LVFS,降低了褪黑激素的心脏保护效应,此效应在24小时再灌注后显著。另外,与IR+Mel组相比,3-TYP增加了梗塞面积、血清LDH水平和凋亡比率。3-TYP(50 mg/kg, i.p.)与Sham组相比,对LVEF、LVFS、梗塞面积、血清LDH水平、凋亡及氧化应激的影响不明显。此外,与Sham组相比,3-TYP对gp91phox、Nrf2、NQO 1、Bax、Bcl-2、Caspase-3及活化Caspase-3的表达水平影响甚微。
细胞实验
Cell viability is analyzed using Cell Counting Kit-8. 1×104 cells are inoculated into 96-well plates. After being treated, 90 μL of medium and 10 μL of CCK-8 solution are added to each well. The cells are then incubated at 37°C for 2 h. After incubation, the absorption at 450 nm is measured using an Infinite? M200 Microplate Reader. The results are expressed as a percentage of the control. The cell death is also evaluated using the trypan blue assay. HepG2 cells are plated in the 6-well plates (5×105 cells per well) and incubated for 24 h. After being treated with Cd or melatonin, the cells are detached with 300 μL trypsin-EDTA solution. The mixture of detached cells is centrifugated at 300 g for 5 min. Then, the residue is combined with 800 μL trypan blue solution and dispersed. After 3 min staining, cells are counted using an automated cell counter. The dead cells are stained with the blue color. Cell mortality (%) is expressed as percentage of the dead cell number/the total cell number.
动物实验
3-TYP is formulated in 1% ethanol.Male C57BL/6 mice are anesthetized with 2% isoflurane, and myocardial ischemia is produced by temporarily exteriorizing the heart via a left thoracic incision and placing a 6-0 silk suture slipknot around the left anterior descending coronary artery. After 30 minutes of myocardial ischemia, the slipknot is released, and the myocardium is reperfused for 3 hour (for western blot analysis and oxidative stress measurement) or 24 hour (for cardiac function, apoptotic index and infarct size determination). Sham-operated mice undergo the same surgical procedures except the suture placed under the left coronary artery is not tied. Ten minutes before reperfusion, mice are randomized to receive either vehicle (1% ethanol) or melatonin (20 mg/kg) by intraperitoneal injection. C57BL/6 mice are randomly divided into the following groups: (i) Sham group: mice underwent the sham operation and are treated with vehicle (1% ethanol); (ii) Mel group: mice are treated with melatonin (20 mg/kg via intraperitoneal injection); (iii) IR+V group: mice underwent the MI/R operation and are treated with vehicle (1% ethanol); (iv) IR+Mel group: mice underwent the MI/R operation and are treated with melatonin (20 mg/kg via intraperitoneal injection 10 minutes before reperfusion); (v) IR+Mel+3-TYP group: mice are pretreated with 3-TYP (3-TYP is intraperitoneally injected at a dose of 50 mg/kg every 2 days for a total of three doses prior to the MI/R surgery), subjected to the MI/R operation, and treated with melatonin (20 mg/kg via intraperitoneal injection 10 minutes before reperfusion); and (vi) IR+3-TYP group: mice are pretreated with 3-TYP and then subjected to the MI/R operation.
别名3-(1H-1,2,3-triazol-4-yl) pyridine
化学信息
分子量146.15
分子式C7H6N4
CAS No.120241-79-4
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
H2O: 5 mg/mL (34.21 mM)
Ethanol: 28 mg/mL (191.6 mM)
DMSO: 65 mg/mL (444.75 mM)
溶液配制表
H2O/Ethanol/DMSO
1mg5mg10mg50mg
1 mM6.8423 mL34.2114 mL68.4229 mL342.1143 mL
5 mM1.3685 mL6.8423 mL13.6846 mL68.4229 mL
10 mM0.6842 mL3.4211 mL6.8423 mL34.2114 mL
20 mM0.3421 mL1.7106 mL3.4211 mL17.1057 mL
Ethanol/DMSO
1mg5mg10mg50mg
50 mM0.1368 mL0.6842 mL1.3685 mL6.8423 mL
100 mM0.0684 mL0.3421 mL0.6842 mL3.4211 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy 3-TYP | purchase 3-TYP | 3-TYP cost | order 3-TYP | 3-TYP chemical structure | 3-TYP in vivo | 3-TYP in vitro | 3-TYP formula | 3-TYP molecular weight